Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Blood. 2019 Dec 26;134(26):2361-2368. doi: 10.1182/blood.2019001641.
Blood. 2019.
PMID: 31650176
Free PMC article.
Clinical Trial.